Servicio de Cirugía Torácica, Hospital 12 de Octubre, Madrid, España.
Servicio de Cirugía General y Torácica, Hospital Universitario Virgen Macarena, Sevilla, España.
Arch Bronconeumol. 2014 Feb;50(2):57-61. doi: 10.1016/j.arbres.2013.05.007. Epub 2013 Jul 23.
Surgical treatment of stage I non-small cell lung cancer (NSCLC) can be performed either by thoracotomy or by employing video-assisted thoracic surgery (VATS). The aim of this study was to compare long and short-term results of conventional surgery (CS) vs. VATS lobectomy in the treatment of stage I NSCLC.
We performed a retrospective, analytical study of patients undergoing surgery for stage I NSCLC during the period January 1993 to December 2005. The variables analyzed were overall survival, recurrence, distant metastasis, morbidity, mortality and hospital stay. During this period, 256 anatomic lung resections were performed: 141 by CS and 115 by VATS.
There were statistically significant differences in: (i)mean hospital stay in patients with no complications (VATS group: 4.3 days vs. CS group: 8.7 days, P=.0001); (ii)mean hospital stay in patients with complications (VATS: 7.2 days vs. CS: 13.7 days, P=.0001), and (iii)morbidity (VATS: 15.6% vs. CS: 36.52%, P=.0001). No statistically significant differences were found in: (i)mortality (VATS: 2.17% vs. CS: 1.7%, P=.88); (ii)5-year overall survival (VATS: 68.1% vs. CS: 63.8%), and (iii) local recurrence and distant metastasis (P=.82).
VATS lobectomy is a safe and effective approach, with a shorter hospital stay and lower morbidity than CS; no statistically significant differences were observed in survival in patients undergoing surgery for stage I NSCLC.
I 期非小细胞肺癌(NSCLC)的外科治疗可以通过开胸手术或电视辅助胸腔镜手术(VATS)进行。本研究旨在比较传统手术(CS)与 VATS 肺叶切除术治疗 I 期 NSCLC 的长期和短期结果。
我们对 1993 年 1 月至 2005 年 12 月期间接受 I 期 NSCLC 手术的患者进行了回顾性、分析性研究。分析的变量包括总生存率、复发率、远处转移率、发病率、死亡率和住院时间。在此期间,共进行了 256 例解剖性肺切除术:141 例采用 CS,115 例采用 VATS。
在以下方面存在统计学显著差异:(i)无并发症患者的平均住院时间(VATS 组:4.3 天 vs. CS 组:8.7 天,P=.0001);(ii)有并发症患者的平均住院时间(VATS:7.2 天 vs. CS:13.7 天,P=.0001),以及(iii)发病率(VATS:15.6% vs. CS:36.52%,P=.0001)。在以下方面未发现统计学显著差异:(i)死亡率(VATS:2.17% vs. CS:1.7%,P=.88);(ii)5 年总生存率(VATS:68.1% vs. CS:63.8%),以及(iii)局部复发和远处转移(P=.82)。
VATS 肺叶切除术是一种安全有效的方法,与 CS 相比,其住院时间更短,发病率更低;在接受 I 期 NSCLC 手术的患者中,生存率没有统计学显著差异。